Succinobucol | m-entrepreneurship.com

Product Name :
Succinobucol

Search keywords :
Succinobucol

drugId :
null

Target Vo:
Vascular cell adhesion molecule 1

Target Vo Short Name :
VCAM1

Moa_Name:
Lipid peroxidation inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Atherogenics Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Angina, Unstable

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Disitamab vedotin Autophagy
Phospho-PKC alpha (T638)Rabbit mAb Purity & Documentation
Anoctamin 1 Antibody: Anoctamin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody, targeting to Anoctamin-1 (ANO1). It can be used for IHC-P, FC assays in the background of Human.

Author: Betaine hydrochloride

Related Posts